Showing results (301-310 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|April 29, 2008
Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adultsArístides Aguilar-Betancourt, Carlos Alberto González-Delgado, Z Cinza-Estévez, et al.Human Vaccines|April 10, 2008
Protective immunity following vaccination: how is it defined?Ian J Amanna, Ilhem Messaoudi, Mark K SlifkaHuman Vaccines|April 10, 2008
Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinationsEmmanuel Vidor, Stanley A PlotkinHuman Vaccines|April 1, 2008
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccineTzou-Yien Lin, Ying-Hsiang Wang, Yhu-Chering Huang, et al.Human Vaccines|March 15, 2008
The changing epidemiology of severe cytomegalovirus disease in AustraliaHolly Seale, C Raina Macintyre, Dominic E Dwyer, et al.Human Vaccines|April 3, 2008
A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza AJulie A McMurry, Bert E Johansson, Anne S De GrootHuman Vaccines|September 24, 2010
Immunogenicity, safety and tolerance of a purified duck embryo vaccine (PDEV, VAXIRAB) for rabies post-exposure prophylaxis: Results of a multicentric study in IndiaBangalore Jayakrishna Mahendra, Shampur Narayan Madhusudana, Gadey Sampath, et al.Human Vaccines|October 29, 2010
Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in JapanHideyuki Ikematsu, Hideaki Nagai, Masahiro Kawashima, et al.Human Vaccines|October 19, 2010
Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccineMichel Deschuyteneer, Abdelatif Elouahabi, Dominique Plainchamp, et al.Pageof 64